News

Oakworth Capital Inc.'s Impressive Earnings Growth in 2025

Oakworth Capital Inc.'s Impressive Earnings Growth in 2025

Oakworth Capital Reports Strong Earnings Performance

Oakworth Capital Inc. has recently announced a notable 22% increase in diluted earnings per share (EPS) for the first nine months of the year. The financial institution, known as Oakworth, reports that its performance has seen substantial improvements compared to the previous year, showcasing remarkable growth in various financial metrics.

Income and Profitability Highlights

This year's financial results depict a thriving business environment for Oakworth Capital. The company reported a net income of $14.5 million, reflecting a 24% increase from last year’s $11.7 million. The diluted earnings per share rose to $2.90, up from $2.37 in the same period last year, marking a significant milestone for the organization.

In terms of overall revenue, Oakworth achieved $60.6 million, which is a remarkable 17% higher than the $51.7 million recorded in the same period of 2024. Additionally, it has reported a pre-tax pre-provision income of $22.1 million, which is up 28% from $17.3 million year-over-year.

Growth in Net Interest Income

Net interest income exhibited steady progress with a 4% linked-quarter growth and an impressive year-over-year rise of 21%. This growth has contributed to the bank's increasing profitability and sustainability in a competitive marketplace. Meanwhile, trust and wealth fees have seen a linked-quarter increase of 7% and an 11% jump year-over-year, showcasing the bank's expanding wealth management services.

Asset Growth and Balance Sheet Strength

Oakworth's wealth assets have also experienced significant growth, now standing at $2.6 billion—11% higher than the previous year's $2.3 billion. On the lending side, the company enjoyed a year-over-year loan growth averaging 13%, with a period-end growth rate of 9%, bringing total loans to $1.5 billion, underscoring the bank's robust loan portfolio.

In addition, deposits saw an average increase of 14% and a period-end growth of 11%, totaling $1.7 billion. The tangible book value per share is recorded at $29.27, giving shareholders an attractive valuation of their investment.

Commitment to Safety and Soundness

Oakworth Capital takes great pride in maintaining high credit quality metrics, with non-performing loans amounting to just $0.5 million and no loans past due by more than 90 days. The bank's total risk-based capital ratio stands at 12.2%, with Common Equity Tier 1 (CET1) capital at 11.0% and a Tier 1 leverage ratio of 9.8%, showcasing a solid capital position.

CEO's Optimistic Outlook

Scott Reed, Chairman and CEO of Oakworth, expressed satisfaction with the company's balanced growth and profitability. He stated, "We've achieved double-digit compound annual growth rates in loans, deposits, wealth assets, and earnings per share for the life of our company. I'm incredibly optimistic about Oakworth's future and the value we're creating for our shareholders and the communities we serve." This sentiment reflects the bank's confidence and strategic direction moving forward.

About Oakworth Capital Inc.

Oakworth Capital, Inc. operates as the bank holding company for Oakworth Capital Bank. Founded in 2008, Oakworth has expanded its footprint across four offices in the Southeast, including its headquarters in Birmingham. The bank provides a variety of services including commercial and private banking, along with wealth management and advisory services to clients throughout the United States.

Ranked among American Banker's "Best Banks to Work For" for eight consecutive years—with six years at the top—Oakworth continues to prioritize customer satisfaction. With a commendable Net Promoter Score of 94 and a client retention rate of 95%, Oakworth has solidified its reputation for excellence in service delivery.

As of recent reports, Oakworth proudly manages total assets of $1.9 billion, gross loans of $1.5 billion, deposits totaling $1.7 billion, and wealth and trust assets amounting to $2.6 billion.

Frequently Asked Questions

What did Oakworth Capital Inc. report about its earnings?

Oakworth Capital Inc. reported a 22% increase in diluted earnings per share for the first nine months, reaching $2.90.

How much net income did Oakworth Capital achieve?

Oakworth Capital's net income was reported at $14.5 million, up 24% from $11.7 million from the previous year.

What are Oakworth's total assets as of September 2025?

The company has reported total assets of $1.9 billion as of September 30, 2025.

How has Oakworth's loan portfolio grown recently?

Oakworth experienced a 13% year-over-year growth in loans, totaling $1.5 billion by the end of the reporting period.

What is the future outlook for Oakworth Capital?

CEO Scott Reed expressed strong optimism regarding the bank's growth trajectory and continued value creation for shareholders and clients alike.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 279

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 235

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 757

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 293

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 930

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading

Top 5 Most Recently Viewed Articles

Bovespa Sinks Slightly as Market Adjusts; Key Movers Identified

Updated Category News Views 169

Overview of Market Movements in Brazil In the latest market update, stocks in Brazil saw a decline, marking a shift in investor sentiment. The Bovespa index, which is a significant indicator of market performance, dropped by 0.03%. Key sectors contributing to this decline included Financials, Electric Power, and Consumption, as a wave of selling pressure led shares lower....

Continue Reading
Unveiling Queens' Artistic Spirit at New JFK Terminal 6

Updated Category News Views 187

Embracing Art at JFK Terminal 6 Excitement is building for the new Terminal 6 at JFK International Airport, set to redefine traveling in New York with its innovative and community-oriented approach. This landmark terminal will showcase a rotating series of artworks from Queens-based artists, adding a vibrant cultural essence to the airport atmosphere. The 'Queens in...

Continue Reading
Market Outlook: BoE Rate Decision and Trade Dynamics

Updated Category News Views 128

Market Overview: Upcoming BoE Rate Decision As we look ahead to the coming week, all eyes are on the Bank of England's (BoE) impending decision regarding interest rates. This moment is poised to be a pivotal event in economic circles, as the central bank has the tough task of weighing inflation against growth in a market characterized by uncertainty. With inflationary...

Continue Reading
Stellantis Faces Profound Challenges Amid Dividend Concerns

Updated Category News Views 189

Stellantis (NASDAQ: STLA) saw its share price tumble over 4%, marking its lowest point since July 2022. This sharp decline didn’t just come out of nowhere; it was fueled by rising doubts surrounding the automaker's ability to sustain dividends after a concerning profit warning was issued earlier this week. Profit Warning Fallout: What Went Wrong? The profit warning has...

Continue Reading
Vistry Group Faces 30% Share Drop After Profit Guidance Cuts

Updated Category News Views 165

Vistry Group Shares Plummet Following Profit Guidance Revision Recently, Vistry Group Plc (LON: VTYV) experienced a significant decline in its share value, which dropped by 30% following a disappointing trading update. This announcement outlined a substantial reduction in profit expectations for the 2024 financial year due to unforeseen cost issues associated with their...

Continue Reading